Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05469165
PHASE2

Serotonin Receptor Blockers in Ischemic Mitral Regurgitation

Sponsor: Laval University

View on ClinicalTrials.gov

Summary

This study is intended to investigate the effect of cyproheptadine (a 5HT2B receptor blocker) on mitral regurgitation severity.

Official title: Blocking the Effects of Serotonin to Prevent Ischemic Mitral Regurgitation: a Randomized Trial (CYPRO-MR)

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

214

Start Date

2023-06-20

Completion Date

2027-09

Last Updated

2023-11-15

Healthy Volunteers

No

Interventions

DRUG

Cyproheptadine 4 Mg Oral Tablet

Cyproheptadine treatment for 3 months

OTHER

Placebo

Placebo administration for 3months

Locations (1)

Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

Québec, Canada